Compound W

Description

Compound W is a fast-acting liquid formulation containing salicylic acid as the active ingredient. It is designed for maximum strength efficacy in the treatment of common warts. The product is packaged in a net weight of 0.31 fluid ounces (9 mL).

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. For optimal results, the wart may be soaked in warm water for approximately 5 minutes. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be applied at a time to ensure sufficient coverage of each wart. It is important to allow the application to dry completely before proceeding.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application is prohibited on irritated skin or any area that is infected or reddened, as this may exacerbate the condition. The product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes due to the potential for adverse reactions. Additionally, individuals with diabetes or poor blood circulation should not use this product, as it may pose increased risks in these populations.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire and flame to prevent any risk of ignition.

The product should not be applied to irritated skin or any area that is infected or reddened. It is contraindicated for use on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, individuals with diabetes or poor blood circulation should refrain from using this product due to potential complications.

If discomfort persists after application, it is imperative to discontinue use and consult a healthcare professional for further evaluation and guidance.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222 without delay.

Side Effects

Patients should be aware of several important warnings and precautions associated with the use of this product. It is intended for external use only and is flammable; therefore, it should be kept away from fire and flame.

The product should not be used on irritated skin or on any area that is infected or reddened. Additionally, it is contraindicated for use on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes. Patients with diabetes or poor blood circulation should also refrain from using this product.

While using this product, patients should avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory discomfort.

Patients are advised to stop using the product and consult a doctor if discomfort persists. It is crucial to keep the product out of reach of children. In case of accidental ingestion, medical help should be sought immediately, or the Poison Control Center should be contacted at 1-800-222-1222.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Compound W (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should not use this product without first consulting a healthcare provider. It is essential for healthcare professionals to evaluate the potential risks and benefits before prescribing this product to women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of Compound W Liquid in lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance immediately or contact a Poison Control Center at 1-800-222-1222.

Patients should be instructed not to use the product on irritated skin or any area that appears infected or reddened. It is important to inform patients that the product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, patients with diabetes or poor blood circulation should be cautioned against using this product.

Healthcare providers should encourage patients to discontinue use and consult a doctor if discomfort persists after application. Patients must be reminded to avoid contact with the eyes while using the product; if contact occurs, they should flush the eye with water for 15 minutes. It is also advisable to instruct patients to avoid inhaling vapors from the product.

Finally, patients should be informed to cap the bottle tightly after use and store it at room temperature, away from heat sources, to maintain product integrity.

Storage and Handling

The product is supplied in a container that requires careful handling to maintain its integrity. It should be stored at room temperature, ensuring that it is kept away from excessive heat, specifically temperatures exceeding 37°C (99°F).

To ensure proper hygiene and prevent contamination, it is recommended to wipe the rim of the bottle with a paper towel between uses. This practice helps maintain the quality of the product and ensures safe handling.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Compound W, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)